Dr. Javier Pinilla-Ibarz, MD, PhD

Claim this profile

Moffitt Cancer Center

Studies T-Lymphoblastic Leukemia/Lymphoma
Studies Lymphoma
3 reported clinical trials
5 drugs studied

Area of expertise

1T-Lymphoblastic Leukemia/Lymphoma
Javier Pinilla-Ibarz, MD, PhD has run 3 trials for T-Lymphoblastic Leukemia/Lymphoma. Some of their research focus areas include:
b3a2 (e14a2) positive
b2a2 (e13a2) positive
MYC positive
2Lymphoma
Javier Pinilla-Ibarz, MD, PhD has run 2 trials for Lymphoma. Some of their research focus areas include:
MYC positive
BCL2 positive
BCL6 positive

Affiliated Hospitals

Image of trial facility.
H. Lee Moffitt Cancer Center And Research Institute
Image of trial facility.
Moffitt Cancer Center

Clinical Trials Javier Pinilla-Ibarz, MD, PhD is currently running

More about Javier Pinilla-Ibarz, MD, PhD

Clinical Trial Related5 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Javier Pinilla-Ibarz, MD, PhD has experience with
  • PRGN-3007
  • BCR-ABL Tyrosine Kinase Inhibitor (TKI)
  • Ruxolitinib
  • Ibrutinib
  • YTB323

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Javier Pinilla-Ibarz, MD, PhD specialize in?
Javier Pinilla-Ibarz, MD, PhD focuses on T-Lymphoblastic Leukemia/Lymphoma and Lymphoma. In particular, much of their work with T-Lymphoblastic Leukemia/Lymphoma has involved b3a2 (e14a2) positive patients, or patients who are b2a2 (e13a2) positive.
Is Javier Pinilla-Ibarz, MD, PhD currently recruiting for clinical trials?
Yes, Javier Pinilla-Ibarz, MD, PhD is currently recruiting for 1 clinical trial in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Javier Pinilla-Ibarz, MD, PhD has studied deeply?
Yes, Javier Pinilla-Ibarz, MD, PhD has studied treatments such as PRGN-3007, BCR-ABL Tyrosine Kinase Inhibitor (TKI), Ruxolitinib.
What is the best way to schedule an appointment with Javier Pinilla-Ibarz, MD, PhD?
Apply for one of the trials that Javier Pinilla-Ibarz, MD, PhD is conducting.
What is the office address of Javier Pinilla-Ibarz, MD, PhD?
The office of Javier Pinilla-Ibarz, MD, PhD is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.